drugsfda_search.json•1.27 kB
{
"meta": {
"results": {
"skip": 0,
"limit": 10,
"total": 25
}
},
"results": [
{
"application_number": "BLA125514",
"sponsor_name": "MERCK SHARP DOHME",
"openfda": {
"application_number": ["BLA125514"],
"brand_name": ["KEYTRUDA"],
"generic_name": ["PEMBROLIZUMAB"],
"manufacturer_name": ["Merck Sharp & Dohme Corp."],
"substance_name": ["PEMBROLIZUMAB"]
},
"products": [
{
"product_number": "001",
"reference_drug": "Yes",
"brand_name": "KEYTRUDA",
"active_ingredients": [
{
"name": "PEMBROLIZUMAB",
"strength": "100MG/4ML"
}
],
"reference_standard": "Yes",
"dosage_form": "INJECTION, SOLUTION",
"route": "INTRAVENOUS",
"marketing_status": "Prescription"
}
],
"submissions": [
{
"submission_type": "BLA",
"submission_number": "125514",
"submission_status": "AP",
"submission_status_date": "20140904",
"submission_class_code": "BLA",
"submission_class_code_description": "Biologic License Application"
}
]
}
]
}